Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Researchers from the Department of Biomedicine describe the atomic details responsible for the short length of actin filaments in the malaria parasite.
The brain cancer immunology and therapy group will participate at the science fair in Bergen, together with the patient organization for brain tumors, hjernesvulstforeningen.
Do human cancer cell lines really behave in the same way as clinical tumor material?
PhD candidate Pouda Panahandeh gives her trial lecture for the degree of PhD at the Faculty of Medicine.
Mathematical modeling and systems biology explain the evolutionary transition from a four-step to a two-step pathway for the synthesis of NAD from vitamin B3.
Our new paper on entangling selectivity determining features and on how to use this knowledge to design selective ligands has been published in J Med Chem!
N-terminal acetylation is a very common protein modification and NAA10 is the major responsible enzyme in human cells. Here we found a novel pathological NAA10 variant, NAA10 p. (R83H), in two boys with developmental delay and intellectual disabilities.
Arvid Lundervold from the Department of Biomedicine receives the award for best teacher at the Faculty of Medicine in 2018.
The week-long matrix biology (BMED904) course was held for 4th time at the Dept. of biomedicine and next BMED904 course will be given in June 2021.
Two PNAS articles from the Arnesen lab are elected as the best publication of the year 2018 at the Faculty of Medicine. The prize will be awarded at the Faculty Day on 13 June 2019.
On May 23 and 24, 2019, the world's leading fibrosis and cancer researchers met in Bergen at an international fibrosis conference on the topic "New tools to study the fibrotic stroma".
The structure of full-length phenylalanine hydroxylase in complex with the cofactor BH4 is presented in the most recent issue of PNAS. As the cofactor is also used as a therapy for PKU, this structure is of medical importance.
The candidate will give a trial lecture and defend her doctoral thesis with the title: “The Receptor Tyrosine Kinase Axl in Tumour Phenotyptic Plasticity and Acquired Resistance to Cancer Targeted- and Immunotherapy"
As the first lab in Norway, the NAT lab recently installed a HoloMonitor system for 3D live cell microscopy. This novel instrument allows us to spy on the cells in a gentle and non-invasive way.
Researchers from the lab of Aurora Martinez describe a novel mechanism for the degradation of enzymes involved in phenylketonuria and other neurometabolic disorders.

Pages